Health-care companies were more or less flat as traders rotated back into a sector that took the brunt of last week's selloff.
Shares of vaccine makers such as Moderna and Novavax rose, following a plunge last week.
The health-care sector "dropped over half of the year to date gain last week alone," said J.D. Joyce, president of Houston financial advisory Joyce Wealth Management. "It begs the question 'why?' and I'm guessing some of that has to do with many potential cabinet picks and what that my mean for the sector."
Drug-store chain CVS Health is adding four new members to its board in an agreement with activist investment firm Glenview Capital Management.
The pharmaceutical sector outlook looks more challenging going into 2025 as investors weigh more attractive alternatives in other sectors, said analysts at Barclays.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
November 18, 2024 16:58 ET (21:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。